These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25650405)

  • 1. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.
    Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional brain alterations in Cushing's syndrome.
    Papakokkinou E; Ragnarsson O
    Front Endocrinol (Lausanne); 2023; 14():1163482. PubMed ID: 37152946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Alterations and Cardiovascular Outcomes of Cortisol Excess.
    Pivonello R; De Martino MC; Iacuaniello D; Simeoli C; Muscogiuri G; Carlomagno F; De Leo M; Cozzolino A; Colao A
    Front Horm Res; 2016; 46():54-65. PubMed ID: 27212264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function and cerebral assessment in patients who have Cushing's syndrome.
    Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity of Cushing's Syndrome and Impact of Treatment.
    Webb SM; Valassi E
    Endocrinol Metab Clin North Am; 2018 Jun; 47(2):299-311. PubMed ID: 29754633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible and the irreversible structural alterations on brain after resolution of hypercortisolism in Cushing's disease.
    Jiang H; Liu C; Pan SJ; Ren J; He NY; Sun YH; Bian LG; Yan FH; Yang WJ; Sun QF
    Steroids; 2019 Nov; 151():108457. PubMed ID: 31326450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing's disease: a case-control study.
    Andela CD; van der Werff SJ; Pannekoek JN; van den Berg SM; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Romijn JA; Tiemensma J; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2013 Dec; 169(6):811-9. PubMed ID: 24031092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.
    Bourdeau I; Bard C; Noël B; Leclerc I; Cordeau MP; Bélair M; Lesage J; Lafontaine L; Lacroix A
    J Clin Endocrinol Metab; 2002 May; 87(5):1949-54. PubMed ID: 11994323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac disease in Cushing's syndrome. Emphasis on the role of cardiovascular magnetic resonance imaging.
    Moustaki M; Markousis-Mavrogenis G; Vryonidou A; Paschou SA; Mavrogeni S
    Endocrine; 2024 Mar; 83(3):548-558. PubMed ID: 38129722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral atrophy in Cushing's disease.
    Simmons NE; Do HM; Lipper MH; Laws ER
    Surg Neurol; 2000 Jan; 53(1):72-6. PubMed ID: 10697236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome.
    Resmini E; Santos A; Gómez-Anson B; Vives Y; Pires P; Crespo I; Portella MJ; de Juan-Delago M; Barahona MJ; Webb SM
    J Clin Endocrinol Metab; 2012 Feb; 97(2):663-71. PubMed ID: 22162471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.
    Crespo I; Santos A; Gómez-Ansón B; López-Mourelo O; Pires P; Vives-Gilabert Y; Webb SM; Resmini E
    Endocrine; 2016 Sep; 53(3):848-56. PubMed ID: 27103571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric magnetic resonance imaging analysis in patients with short-term remission of Cushing's disease.
    Jiang H; Ren J; He NY; Liu C; Sun YH; Jian FF; Bian LG; Shen JK; Yan FH; Pan SJ; Sun QF
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):367-374. PubMed ID: 28543178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical consequences of Cushing's syndrome.
    Valassi E; Crespo I; Santos A; Webb SM
    Pituitary; 2012 Sep; 15(3):319-29. PubMed ID: 22527617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy.
    Resmini E; Santos A; Gómez-Anson B; López-Mourelo O; Pires P; Vives-Gilabert Y; Crespo I; Portella MJ; de Juan-Delago M; Webb SM
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):700-7. PubMed ID: 23594250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels.
    Valassi E; Crespo I; Keevil BG; Aulinas A; Urgell E; Santos A; Trainer PJ; Webb SM
    Eur J Endocrinol; 2017 Feb; 176(2):221-231. PubMed ID: 27932530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol Excess and the Brain.
    Resmini E; Santos A; Webb SM
    Front Horm Res; 2016; 46():74-86. PubMed ID: 27210466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission.
    Ragnarsson O; Stomby A; Dahlqvist P; Evang JA; Ryberg M; Olsson T; Bollerslev J; Nyberg L; Johannsson G
    Psychoneuroendocrinology; 2017 Aug; 82():117-125. PubMed ID: 28544904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitfalls in the diagnosis and management of Cushing's syndrome.
    Bansal V; El Asmar N; Selman WR; Arafah BM
    Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.